Obida, Janeth M.

HRN: 15-41-26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2022
CEFUROXIME 1.5GM (VIAL)
11/22/2022
11/29/2022
IV
1.5g
Q8H
Uti
Waiting Final Action 
11/22/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/22/2022
11/29/2022
IV
500mg
Q8H
AP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: